IperionX Limited carries a market capitalization of 787.64M, placing it among publicly traded companies globally. Its enterprise value stands at 571.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 787.64M |
| Enterprise Value | 571.68M |
IperionX Limited currently has 315.85M shares outstanding.
| Shares Outstanding | 315.85M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
IperionX Limited maintains a current ratio of 25.42, meaning it holds 25.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 25.42 |
| Quick Ratio | 23.32 |
| Debt / Equity | 6.87 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
IperionX Limited's stock has declined approximately -51.66667% over the past 52 weeks. The 50-day moving average sits at 2.35, while the 200-day moving average is 3.38.
| Beta (5Y) | N/A |
| 52-Week Price Change | -51.66667% |
| 50-Day Moving Average | 2.35 |
| 200-Day Moving Average | 3.38 |
| Average Volume (20 Days) | N/A |
| Operating Cash Flow | N/A |
| Capital Expenditures | -14.05M |
| Free Cash Flow | -14.05M |
| FCF Per Share | N/A |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -16.85 |
| FCF Yield | N/A |
IperionX Limited posts an Altman Z-Score of 149.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 149.87 |